Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
192311011000036112 | Synagis (palivizumab 50 mg) powder for injection, 50 mg vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
192312011000036118 | Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | Is a | Synagis | true | Inferred relationship | Some | ||
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | Is a | palivizumab 50 mg injection, vial | true | Inferred relationship | Some | ||
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | has unit of use | vial | true | Inferred relationship | Some | 27556397 | |
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | has Australian BoSS | palivizumab | true | Inferred relationship | Some | 27556396 | |
Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | has intended active ingredient | palivizumab | true | Inferred relationship | Some | 27556396 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Synagis (1 x 50 mg vial, 1 x 1 mL inert diluent ampoule), 1 pack | has TPUU | True | Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | Inferred relationship | Some | 1 |
Synagis (inert substance) diluent [1 x 1 mL ampoule] (&) (palivizumab 50 mg) powder for injection [1 x 50 mg vial], 1 pack (containered trade product pack) | has TPUU | True | Synagis (palivizumab 50 mg) powder for injection, 50 mg vial | Inferred relationship | Some | 1 |
Reference Sets
Australian dialect reference set
Unit of use quantity reference set
Description inactivation indicator reference set
Trade product unit of use reference set